Cumulus Neuroscience Presents Data at the ISCTM 2026 Autumn Conference

ConferencePositive

AI Analysis

Summary

Cumulus Neuroscience presented interim data at ISCTM 2026 Autumn Conference showing high adherence and usability for remote multimodal brain monitoring in borderline personality disorder and therapy-resistant depression, plus a digital cognitive task comparable to clinical benchmarks for Alzheimer's trial pre-enrichment.

Clinical Trial Data

Importance:4/10

Sentiment:

0.30

conference presentationinterim dataremote monitoringdigital biomarkersborderline personality disordertherapy-resistant depressionAlzheimer's disease

Related Companies

$BNN.DE

Read the original article

Published by PR Newswire Clinical Trials on September 16, 2026 10:00 PM

Read Original